Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial

DOI Full Paper Access

192

Citations

52

References

2022

Year

Yongxiang Xia, Weiwei Tang, Xiaofeng Qian, Xiangcheng Li, Feng Cheng, Ke Wang, Feng Zhang, Chuanyong Zhang, Donghua Li, Jinhua Song,

Journal for ImmunoTherapy of Cancer

Abstract

NCT04297202.

References

	Year	Citations

Page 1